ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Astellas Pharma Inc clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 983 studies whose lead sponsor is Astellas Pharma Inc or one of 23 companies grouped under it. 38 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 17, 2026.

Our grouping of 25 registry names, not the registry’s. See them and correct one ↓

Compare Astellas Pharma with AstraZeneca and Bristol-Myers Squibb →

Pipeline: 20 programs

Each counted once: 20 with a study Astellas Pharma Inc leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)

The 4 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Astellas Pharma Inc’s own registered studies; Astellas Pharma Inc’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Astellas Pharma Inc’s studies test, most open studies first — 136 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 136; every drug is on its own page, and each page lists its sponsors.

Coming up

14 of Astellas Pharma Inc’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 3D
  3. J’27
  4. 1F
  5. M
  6. 1A
  7. 1M
  8. 3J
  9. 1J
  10. A
  11. 1S
  12. 2O
  13. 1N

The 12 nearest

Show 7 more

Add all 14 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 19, 2026.

All 983 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now384%Recruiting 33 · Not yet recruiting 4 · Enrolling by invitation 1
  • Under way, not recruiting202%
  • Completed82784%
  • Stopped early939%Terminated 81 · Withdrawn 12
  • Status unknown or other51%Approved for marketing 3 · No longer available 1 · Available 1

Phase

Where

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 9112
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 2026

By the year each study started; 154 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Astellas Pharma Inc.

  • Astellas Pharma Inc
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    525 studies
  • Astellas Pharma Global Development, Inc.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    207 studies →
  • Astellas Pharma Europe B.V.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    94 studies →
  • Astellas Pharma Europe Ltd.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    31 studies →
  • Astellas Pharma China, Inc.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    24 studies →
  • Astellas Pharma Korea, Inc.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    19 studies →
  • OSI Pharmaceuticals
    Acquired — became part of Astellas Pharma Inc, Jun 3, 2010 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    16 studies →
  • Ophthotech Corporation
    Acquired — became part of Astellas Pharma Inc, Jul 11, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    13 studies →
  • Astellas Institute for Regenerative Medicine
    Acquired — became part of Astellas Pharma Inc, Feb 10, 2016 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    10 studies →
  • Astellas Pharma Singapore Pte. Ltd.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    9 studies →
  • Astellas Gene Therapies
    Acquired — became part of Astellas Pharma Inc, Jan 15, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    9 studies →
  • Astellas Pharma S.A.S.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • IVERIC bio, Inc.
    Acquired — became part of Astellas Pharma Inc, Jul 11, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Ganymed Pharmaceuticals GmbH
    Acquired — became part of Astellas Pharma Inc, Dec 20, 2016 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Astellas Pharma Taiwan, Inc.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Propella Therapeutics
    Acquired — became part of Astellas Pharma Inc, Dec 21, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Agensys, Inc.
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Astellas Pharma a/s
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies
  • Audentes Therapeutics
    Acquired — became part of Astellas Pharma Inc, Jan 15, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Astellas Scientific & Medical Affairs, Inc.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Iota Biosciences, Inc
    Acquired — became part of Astellas Pharma Inc, Oct 29, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Astellas Pharma s.r.o.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Astellas (Beijing) Pharmaceutical R&D Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Ogeda S.A.
    Acquired — became part of Astellas Pharma Inc, May 16, 2017 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Astellas Pharma Canada, Inc.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Astellas Pharma Inc leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 983. Browse all 983 →